Antiparasitic Drug Use and Resistance in Ruminants and Equines; Public Meeting; Request for Comments


Docket No. FDA–2012–N–0102

The Food and Drug Administration (FDA) is announcing a public meeting entitled  “Antiparasitic Drug Use and Resistance in Ruminants and Equines.’’  The purpose of the meeting is to discuss the current state of anthelmintic resistance in the United States and worldwide, tools for the evaluation of antiparasitic resistance, evaluation of the effectiveness of drugs  against resistant parasites, and the scientific rationale for the use of combinations of antiparasitic drugs in ruminants and equines.

The public meeting will be held on March 5 and 6, 2012, from 8 a.m. to 5:30 p.m.

Location: The meeting will be held at the Hilton Washington, DC at the Rockville Hotel & Executive Meeting Center, 1750 Rockville Pike, Rockville, MD 20852–1699; 1–800–774–1500; FAX 301–468–0163.

Interested persons may present data, information, or views, orally or in writing, on the topic of the discussion of the meeting. Written submissions may be made to the contact person on or before February 27, 2012.  Oral presentations from the public during the open public comment period will be scheduled between approximately 2 p.m. and 3 p.m. on March 5, 2012, and 10:30 a.m. and 12 noon on March 6, 2012.

Share This Post